This inventor holds 1 USPTO granted patent and 2 published patent applications. Top assignees: Provincial Health Services Authority, The University of British Columbia. Active years: 2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
1 out of 27 
1 out of 963 
Years Active: 2025
Title: Lei Wang: Innovator in Radiolabeled Compounds
Introduction
Lei Wang is a prominent inventor based in Vancouver, Canada. She has made significant contributions to the field of medical imaging and therapeutic agents. Her innovative work focuses on radiolabeled compounds that target specific receptors in the body.
Latest Patents
Lei Wang holds a patent for "Radiolabeled compounds for in vivo imaging of gastrin-releasing peptide receptor (GRPR) and treatment of GRPR-related disorders." This patent includes peptidic compounds of Formula I, which are designed to be used as imaging agents or therapeutic agents. The compounds feature a variety of amino acids and radiolabeling groups, showcasing her expertise in biochemistry and pharmacology.
Career Highlights
Throughout her career, Lei Wang has worked with notable organizations such as the Provincial Health Services Authority and the University of British Columbia. Her experience in these institutions has allowed her to advance her research and contribute to the scientific community.
Collaborations
Lei Wang has collaborated with esteemed colleagues, including Kuo-Shyan Lin and François Bénard. These partnerships have further enriched her research and innovation in the field.
Conclusion
Lei Wang's contributions to the development of radiolabeled compounds highlight her role as a leading inventor in medical imaging. Her work continues to impact the field and offers promising advancements in the treatment of GRPR-related disorders.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile